DONATE
Français
Ontario
Alberta and Northwest Territories
British Columbia and Yukon
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Cancer information
Loading...
Support & services
Loading...
Prevention & screening
Loading...
Get involved
Loading...
DONATE
Menu
Loading...
Links
Research Horizons
Trending Topics:
HPV
clinical trial
T cell therapy
immunotherapy
Home
Close
immunotherapy
The immune system’s quality control: eliminating cells that could lead to cancer
early diagnosis
Liquid biopsies: promise in lung cancer
genomics
Using existing drugs in a new way to treat bone cancer
prevention
Working the night shift might prevent DNA repair
Research Institute
Merck Canada
Research Impact Report
Prevention Network
Canadian Cancer Trials
News: genomics
Using existing drugs in a new way to treat bone cancer
First approval in US of a cancer drug based on tumour mutations, not tissue site
Matching the right drug to the right ovarian cancer
The link between chromosomal “protective tips” and cancer risk
Personalized medicine: Transforming cancer treatment
Tackling the challenges of childhood brain cancer
HPV status can influence how cervical cancer is treated
Esophageal cancer: One disease or many?
The genetic chaos of cancer cells
Chasing Down Metastatic Cancer
What are ‘targeted’ cancer drugs?
The Crucial Role of Patient Samples in Cancer Research
Supported by:
Next
Canadian Cancer Society
Fighting since 1938
Our mission
Our research
A message from our chair
Our partnerships
Our people
News
Research horizons
Ethical fundraising
Resource publications
Impact report
Financial statements
About our site & information
Our editorial policy
Medical disclaimer
Privacy policy
Linking policy
Accessibility
Terms and conditions
If you need support or have any questions, contact us.
Talk to us
1-888-939-3333
Monday to Friday
TTY
1-866-786-3934
Email us